Form 8-K - Current report:
SEC Accession No. 0001193125-24-236726
Filing Date
2024-10-11
Accepted
2024-10-11 16:10:54
Documents
13
Period of Report
2024-10-08
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K d844510d8k.htm   iXBRL 8-K 23752
  Complete submission text file 0001193125-24-236726.txt   141990

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA nerv-20241008.xsd EX-101.SCH 2878
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE nerv-20241008_lab.xml EX-101.LAB 17236
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nerv-20241008_pre.xml EX-101.PRE 10831
16 EXTRACTED XBRL INSTANCE DOCUMENT d844510d8k_htm.xml XML 3545
Mailing Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451 617-600-7373
Minerva Neurosciences, Inc. (Filer) CIK: 0001598646 (see all company filings)

EIN.: 260784194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36517 | Film No.: 241367673
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)